HealthCare Global Enterprises Limited has announced the record date of March 2, 2026 for its upcoming rights issue worth ₹42,500.00 lakhs. The company's board of directors, in their meeting held on February 24, 2026, approved the detailed terms and timeline for the equity fundraising initiative under Regulations 30 and 42 of the SEBI Listing Regulations.

Rights Issue Structure and Pricing

The rights issue comprises 82,94,566 fully paid-up equity shares with a face value of ₹10.00 each. The company has set the rights issue price at ₹512.00 per share, which includes a premium of ₹502.00 per equity share.

Entitlement and Record Date Details

Shareholders holding equity shares as on the record date of March 2, 2026 will be entitled to participate in the rights issue. The entitlement ratio has been set at 1 rights equity share for every 17 fully paid-up equity shares held on the record date. Rights entitlements will be credited to eligible shareholders' demat accounts under ISIN INE075I20017 prior to the issue opening date.

Issue Timeline and Key Dates

The rights issue follows a structured timeline spanning from March 2026 to April 2026:

Renunciation and Application Process

Rights entitlement holders can renounce their rights either through on-market renunciation via stock exchanges or through off-market transfers. The company has made arrangements with NSDL and CDSL for crediting rights entitlements to eligible shareholders' demat accounts. To receive allotment, rights entitlement holders must submit applications by the issue closing date with full payment. If no application is made by the issue closing date, the rights entitlements will lapse.

Impact on Share Capital

The rights issue will increase the company's outstanding equity shares from 141,007,637 shares to 149,302,203 shares, assuming full subscription. The board retains the right to extend the issue period up to 30 days from the opening date if required.

Regulatory Compliance

The rights issue has been structured in accordance with the Companies Act 2013, SEBI (Issue of Capital and Disclosure Requirements) Regulations 2018, and SEBI Listing Regulations. The company will file the Letter of Offer with SEBI, BSE Limited, and National Stock Exchange of India Limited as part of the regulatory process. The board meeting commenced at 5.00 p.m. and completed at 7.50 p.m. on February 24, 2026.

HealthCare Global Enterprises Limited announced that its board of directors has approved a significant rights issue during their meeting held on February 17, 2026. The healthcare company's board unanimously approved the issuance of fully paid-up equity shares worth up to ₹42,500 Lakhs, marking a major capital raising initiative for the organization.

Rights Issue Details

The board approved the issuance of fully paid-up equity shares with a face value of ₹10 each, targeting eligible equity shareholders as on the record date. The rights issue will be conducted in accordance with applicable laws, including the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended.

Board Meeting Proceedings

The board meeting commenced at 5:00 PM and concluded at 7:25 PM on February 17, 2026. This decision follows the company's prior intimation dated February 8, 2026, indicating that the rights issue had been under consideration by the management.

Terms and Implementation

The board has delegated authority to the Rights Issue Committee of the Board of Directors to determine the specific and detailed terms of the rights issue. Key aspects that will be finalized by the committee include:

• Issue price determination
• Rights entitlement ratio
• Record date specification
• Timing of the rights issue
• Terms of payment

These details will be disclosed to the stock exchanges in due course as they are finalized by the authorized committee.

Regulatory Compliance

The rights issue is subject to obtaining necessary regulatory and statutory approvals as required under applicable laws. The company has filed the required disclosure pursuant to Regulation 30 of SEBI Listing Regulations, along with the circular requirements specified in SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024.

The rights issue represents a significant capital raising exercise for HealthCare Global Enterprises Limited, providing eligible shareholders with the opportunity to participate in the company's growth plans through additional equity investment.